Overview
- 109 inspections across 107 sites are on record.
- 346 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-11-22.
At a glance
Inspections
109
Sites
107
Observations
346
Career since
Aug 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Nivagen Pharmaceuticals, Inc. | 22 Nov 2024 | Human Drugs | On file |
| Hebei Brant Pharmaceutical Co., Ltd. | 12 Sep 2024 | Human Drugs | On file |
| North China Pharmaceutical Huasheng Co., Ltd. | 6 Sep 2024 | Human Drugs | |
| Hubei JXBio Pharmaceutical Co.,Ltd | 30 Aug 2024 | Animal Drugs & Feeds | On file |
| Corden Pharma Bergamo SPA | 26 Jun 2024 | Animal Drugs & Feeds | On file |
Sites inspected
Nivagen Pharmaceuticals, Inc.Davis, United States1 insp.
Hebei Brant Pharmaceutical Co., Ltd.Jinzhou, China1 insp.
North China Pharmaceutical Huasheng Co., Ltd.Shijiazhuang, China1 insp.
Hubei JXBio Pharmaceutical Co.,LtdXianning, China1 insp.
Corden Pharma Bergamo SPATreviglio, Italy1 insp.
Co-investigators
Investigators who share inspections with this person.
Binh T Nguyen5 shared
Kimberly M Lichter4 shared
Darren S Brown3 shared
Carrie A Hughes2 shared
Debra I Love2 shared
Ka L Wong2 shared
Latorie S Jones2 shared
Thuy Tram L Nguyen1 shared
Lena Nguyen1 shared
Vincent Thomas1 shared
Full investigator report
Get the verbatim findings behind Saied A Asbagh's 346 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site